The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Gene Expression Profiling of Cervical Cancer Progression in Biopsies and Tissue Samples
Official Title: Ex Vivo Gene Expression Profiling of Cervical Cancer Progression in Biopsies And Tissue Samples From Patients With Cervical Lesions
Study ID: NCT00629577
Brief Summary: RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research trial is studying gene expression profiling of cervical cancer progression in biopsies and tissue samples from patients with cervical lesions.
Detailed Description: OBJECTIVES: * Classify cervical cancer progression at a molecular level using gene expression profiling generated from expression microarrays. * Profile gene expression changes of dysplasia and early carcinoma of uterine cervical tissue at a molecular level using expression microarrays. * Define a set of genes that classify the various grades of cervical cancer/dysplasia at a molecular level. * Compare the expression profiles of clinical data to determine how accurately cell lines model the in vivo environment. OUTLINE: Patients undergo colposcopy and a cervical smear is taken for flow cytometry analysis. Patients also undergo 2 biopsies from one clinically abnormal or normal site. Tissue samples are analyzed by gene expression profiling using human expression microarrays containing approximately 40,000 unique sequences. Data analysis consists of defining a set of genes, containing new targets for biomarkers, that classify the biopsies into 3 grades.
Minimum Age: 19 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
BC Cancer Research Centre, Vancouver, British Columbia, Canada
Name: Thomas G Ehlen, M.D.
Affiliation: BC Cancer Agency, Vancouver General Hospital
Role: PRINCIPAL_INVESTIGATOR